Riboflavin
Riboflavin (Vitamin B2)
An essential B vitamin that supports energy metabolism and has clinical evidence for reducing migraine frequency.
Riboflavin (Vitamin B2) is essential for energy production as a component of FAD and FMN coenzymes. It's particularly notable for its strong evidence in migraine prevention, where high-dose supplementation (400mg) has been shown to significantly reduce frequency and severity. It also supports antioxidant systems by regenerating glutathione.
Mechanisms of Action
Energy Metabolism
Component of FAD and FMN coenzymes
Antioxidant Regeneration
Helps regenerate glutathione
Mitochondrial Function
Supports mitochondrial energy production
Recommended Dose
25-50mg for general health; 400mg for migraine prevention
Loading: For migraines: 400mg/day, takes 3 months for full effect
Optimal Timing
- With food for better absorption
- Morning with other B vitamins
Take with food
Best Form
Riboflavin or Riboflavin-5-Phosphate (R-5-P)
Alternatives: Standard riboflavin
R-5-P is the active form. Standard riboflavin is well-absorbed and effective for most people.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Best absorbed when taken with food. Higher doses can be split throughout the day.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Migraine Prevention
Significant reduction in migraine frequency
Energy Support
Improved energy metabolism
Bright Yellow Urine
Harmless fluorescent yellow color to urine
400mg/day is well-studied for prevention
Who Should NOT Take This
- Known allergy or hypersensitivity to Riboflavin or related compounds
Drug Interactions
May reduce riboflavin absorption
May increase riboflavin breakdown
May reduce riboflavin absorption in gut
Possible Side Effects
Tip: Expected and harmless
Warnings
- Yellow urine is normal and not a concern
Top studies from 40+ peer-reviewed papers
Kohandel Gargari O et al. • JAMA network open (2024)
“In this network meta-analysis of randomized clinical trials, topiramate and pregabalin were associated with reduction in headache frequency and intensity.”
Key Findings:
- Compared with placebo, pregabalin (ratio of means [RoM], 0.38; 95% CI, 0.18-0.79) and topiramate with vitamin D3 (RoM, 0.44; 95% CI, 0.30-0.65) were associated with reduction in migraine frequency.
- However, no treatments were associated with significant improvements in quality of life or reduction of the duration of migraine attacks.
- Adverse events were higher with amitriptyline (RR, 3.81; 95% CI, 1.41-10.32), topiramate (RR, 4.34; 95% CI, 1.60-11.75), and valproate (RR, 5.93; 95% CI, 1.93-18.23) compared with placebo.
Chen YS et al. • Nutritional neuroscience (2022)
“A pooled analysis of available randomized controlled clinical trials demonstrated that Vitamin B2 400 mg/day for three months supplementation had significant effect on days, duration, frequency, and pain score of migraine attacks.”
Key Findings:
- Vitamin B2 supplementation significantly decreased migraine days (p = .005, I2 = 89%), duration (p = .003, I2 = 0), frequency (p = .001, I2 = 65%), and pain score (p = .015, I2 = 84%).
- A pooled analysis of available randomized controlled clinical trials demonstrated that Vitamin B2 400 mg/day for three months supplementation had significant effect on days, duration, frequency, and pain score of migraine attacks.
- Further research warranted to confirm findings
Talandashti MK et al. • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025)
“The use of certain dietary supplements has resulted in a significant decrease in migraine prophylaxis.”
Key Findings:
- In adults, compared with placebo, these supplements did not significantly affect other outcomes, and omega-3 supplementation did not yield a statistically significant reduction in any of these outcomes.
- The use of certain dietary supplements has resulted in a significant decrease in migraine prophylaxis.
- Further clinical trials of high quality appear to be beneficial.
Bradbury KE et al. • The Cochrane database of systematic reviews (2025)
“The evidence for the effect of oral riboflavin supplements on systolic and diastolic blood pressure is very uncertain.”
Key Findings:
- The evidence for the effect of oral riboflavin supplements on systolic and diastolic blood pressure is very uncertain.
- The evidence comes from four RCTs, three of which had an overall high risk of bias.
- Large, well-conducted trials are needed for high-certainty evidence of the effect of riboflavin for blood pressure lowering.
Buzatu R et al. • Nutrients (2025)
“Conclusions: Across diverse populations, inadequate vitamin B complex intake-especially folate-was consistently linked to worse periodontal outcomes.”
Key Findings:
- In older adults, each standard deviation increase in serum folate was associated with an approximate 26% reduction in periodontal disease odds ratio (OR = 0.74, 95% confidence interval (CI) 0.58-0.93).
- In a large NHANES-based cohort, insufficient thiamine (B1) intake yielded a 33% higher likelihood of severe periodontitis (p < 0.05), while adequate riboflavin was protective (OR = 0.90).
- Another dose-response analysis (n = 8959) indicated up to a 30% risk reduction for moderate folate or B1 intake, but no extra benefit with excessive intake.
- Finally, a UK Biobank analysis (n = 9476) showed that those in the highest quartile of a "high micronutrient" dietary pattern-including vitamins B6 and folate-had a 24% lower risk of self-reported periodontal disease (OR = 0.76, 95% CI 0.65-0.90) compared to the lowest quartile.
Study Type Distribution
Goals This Supplement Supports
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.